Tag: Drug
Trump’s Most Favored Nation Drug Pricing Has Bold Aims, But Limited Impact
The Trump administration is actively pursuing most favored nation (MFN) strategies to bring U.S. prescription drug prices closer…
Marilyn Monroe’s Secret Drug Addiction Shocker Revealed
Anthony Summers, the author of the 1985 biography Goddess: The Secret Lives of Marilyn Monroe, detailed Monroe's struggle…
Huge study of Alzheimer’s genetics identifies new drug targets
Illustration of amyloid plaques, which build up around brain cells in Alzheimer’s disease JUAN GAERTNER/SCIENCE PHOTO LIBRARY/Alamy The…
U.S. strike on alleged drug boat kills 3 in Pacific Ocean, in fourth attack this week : NPR
President Donald Trump speaks during a Cabinet meeting at the White House, Wednesday, May 27, 2026, in Washington,…
Drug Overdose Deaths Fell in 2024. Why Experts Remain Cautious
Overdose deaths dropped sharply in 2024, but many experts warn the deeper drivers of addiction remain unresolved.gettyThe U.S.…
Merck-Kelun lung cancer drug cut tumor progression risk by 65%
Adam Feuerstein is a senior writer and biotech columnist, focusing on drug development, business, Wall Street, and biotechnology.…
Inside Incyte’s $120 Million AI For Drug Development Deal
In this week’s edition of InnovationRx, we delve into a groundbreaking AI drug development partnership, a new pill…
Isomorphic Labs’ $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery
Demis Hassabis, CEO of Isomorphic and Google DeepMind© 2025 Bloomberg Finance LPFounded as an Alphabet entity in 2021,…
Questionable White House Math Savings Most Favored Nation Drug Prices
WASHINGTON, DC - SEPT. 30, 2025: President Trump shakes hands with Pfizer CEO Albert Bourla as he announces…
White House plan on drug strategy runs counter to recent actions
The White House has unveiled a new strategy to tackle the nation's drug crisis, advocating several public health…
Savings from Most-Favored-Nation Drug Pricing Policy – The White House
Executive Summary The Trump Administration has introduced a Most-Favored-Nation (MFN) drug pricing policy to tackle significant disparities in…
Why the FDA rejected a ‘breakthrough’ melanoma drug
RP1, a new drug for patients whose skin cancer does not respond to conventional treatments, has offered hope—at…